Dr. Philip Newsome

Dr. Philip Newsome is Director of the Roger Williams Institute of Liver Studies and the King’s Health Partners Centre for Translational Medicine in the UK. He also leads the metabolic liver service at King’s College Hospital, home to one of the UK’s largest multidisciplinary clinics for non-alcoholic fatty liver disease (NAFLD).
Dr. Newsome has played a pivotal role in shaping international liver health policy. He co-developed the FAST score for risk stratification in non-alcoholic steatohepatitis (NASH) and led the global initiative to redefine NAFLD as metabolic dysfunction-associated steatotic liver disease (MASLD).
His research expertise spans cell therapies for liver disease, fatty liver disease, rare metabolic disorders, and liver transplantation. Dr. Newsome has published over 150 major peer-reviewed research papers.